Literature DB >> 23636930

The diagnosis and treatment of attention deficit hyperactivity disorder in patients with epilepsy.

Mesha-Gay Brown1, Danielle A Becker, John R Pollard, Christopher Todd Anderson.   

Abstract

Attention deficit/hyperactivity disorder (AD/HD) can cause significant impairment in psychosocial and scholastic achievement. AD/HD should be appropriately managed even if patients have comorbid epilepsy. The diagnosis and treatment of AD/HD in patients with epilepsy presents several challenges. Differentiating independent problems in attention from frequent epileptic seizures is the first step in evaluating these individuals. Once this is accomplished the formal independent diagnosis of AD/HD can be pursued. Data from non-epileptic AD/HD populations should be applied with caution to patients with epilepsy. Once attention deficit disorder has been diagnosed formally, choices in treatment can create other problems as some pharmacological treatments for AD/HD pose a risk of exacerbating seizures. This article serves as a review for the diagnosis and treatment of AD/HD spectrum disorders in patients with epilepsy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636930     DOI: 10.1007/s11910-013-0351-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  18 in total

1.  Stimulant therapy and seizure risk in children with ADHD.

Authors:  S A Hemmer; J F Pasternak; S G Zecker; B L Trommer
Journal:  Pediatr Neurol       Date:  2001-02       Impact factor: 3.372

2.  Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).

Authors:  Robert S Fisher; Walter van Emde Boas; Warren Blume; Christian Elger; Pierre Genton; Phillip Lee; Jerome Engel
Journal:  Epilepsia       Date:  2005-04       Impact factor: 5.864

3.  Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.

Authors:  C M van der Feltz-Cornelis; A P Aldenkamp
Journal:  Epilepsy Behav       Date:  2006-02-28       Impact factor: 2.937

4.  Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy.

Authors:  Alcy Torres; Jane Whitney; Sneha Rao; Claire Tilley; Rachel Lobel; Joseph Gonzalez-Heydrich
Journal:  Epilepsy Behav       Date:  2010-12-13       Impact factor: 2.937

5.  The prevalence of atypical presentations and comorbidities of benign childhood epilepsy with centrotemporal spikes.

Authors:  Eliel Tovia; Hadassa Goldberg-Stern; Bruria Ben Zeev; Eli Heyman; Nathan Watemberg; Aviva Fattal-Valevski; Uri Kramer
Journal:  Epilepsia       Date:  2011-06-21       Impact factor: 5.864

6.  Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

Authors:  V Gross-Tsur; O Manor; J van der Meere; A Joseph; R S Shalev
Journal:  J Pediatr       Date:  1997-01       Impact factor: 4.406

7.  Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy.

Authors:  Joseph Gonzalez-Heydrich; Jane Whitney; Deborah Waber; Peter Forbes; Olivia Hsin; Stephen V Faraone; Alice Dodds; Sneha Rao; Christine Mrakotsky; Carlene Macmillan; David R Demaso; Carl de Moor; Alcy Torres; Blaise Bourgeois; Joseph Biederman
Journal:  Epilepsy Behav       Date:  2010-05-21       Impact factor: 2.937

8.  An Evaluation of the Effects of Methylphenidate on Outcomes in Adult Epilepsy Patients.

Authors:  J Layne Moore; James W. McAuley; Lucretia Long; Robert Bornstein
Journal:  Epilepsy Behav       Date:  2002-02       Impact factor: 2.937

9.  Methylphenidate and seizure frequency in brain injured patients with seizure disorders.

Authors:  B A Wroblewski; J M Leary; A M Phelan; J Whyte; K Manning
Journal:  J Clin Psychiatry       Date:  1992-03       Impact factor: 4.384

Review 10.  Does a normalizing electroencephalogram in benign childhood epilepsy with centrotemporal spikes abort attention deficit hyperactivity disorder?

Authors:  Nira Schneebaum-Sender; Hadassa Goldberg-Stern; Aviva Fattal-Valevski; Uri Kramer
Journal:  Pediatr Neurol       Date:  2012-10       Impact factor: 3.372

View more
  2 in total

Review 1.  Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.

Authors:  Chris Eaton; Kenneith Yong; Victoria Walter; Gashirai K Mbizvo; Sinead Rhodes; Richard Fm Chin
Journal:  Cochrane Database Syst Rev       Date:  2022-07-13

2.  Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review.

Authors:  Johanne Telnes Instanes; Kari Klungsøyr; Anne Halmøy; Ole Bernt Fasmer; Jan Haavik
Journal:  J Atten Disord       Date:  2016-09-01       Impact factor: 3.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.